Concourse Financial Group Securities’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10065 |
|
|
2024
Q4 | – | Sell |
-3
| Closed | -$30 | – | 10081 |
|
|
2024
Q3 | $30 | Hold |
3
| – | – | ﹤0.01% | 2226 |
|
|
2024
Q2 | $25 | Hold |
3
| – | – | ﹤0.01% | 2288 |
|
|
2024
Q1 | $91 | Hold |
3
| – | – | ﹤0.01% | 2273 |
|
|
2023
Q4 | $74 | Hold |
3
| – | – | ﹤0.01% | 2243 |
|
|
2023
Q3 | $168 | Hold |
3
| – | – | ﹤0.01% | 2255 |
|
|
2023
Q2 | $283 | Hold |
3
| – | – | ﹤0.01% | 2267 |
|
|
2023
Q1 | $491 | Hold |
3
| – | – | ﹤0.01% | 2248 |
|
|
2022
Q4 | $1.07K | Hold |
3
| – | – | ﹤0.01% | 2155 |
|
|
2022
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 1949 |
|
|
2022
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 2158 |
|
|
2022
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 2139 |
|
|
2021
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 2336 |
|
|
2021
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 2254 |
|
|
2021
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 2325 |
|
|
2021
Q1 | $2K | Hold |
3
| – | – | ﹤0.01% | 2172 |
|
|
2020
Q4 | $2K | Hold |
3
| – | – | ﹤0.01% | 2129 |
|
|
2020
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 2123 |
|
|
2020
Q2 | $2K | Hold |
3
| – | – | ﹤0.01% | 1944 |
|
|
2020
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 2116 |
|
|
2019
Q4 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 1939 |
|
|
2019
Q3 | – | Sell |
-3
| Closed | -$2K | – | 5852 |
|
|
2019
Q2 | $2K | Hold |
3
| – | – | ﹤0.01% | 2045 |
|
|
2019
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 2198 |
|
|
2018
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 2065 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5516 |
|